drugset / Trial / NCT01868126

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT01868126

Phase 2 Completed 91 enrolled Santen Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of four concentrations of DE-117 ophthalmic solution.

Timeline

Start
2013-05
Primary completion
2013-08
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical
Subject omidenepag isopropyl Small molecule Topical

Indications